Evidence map›Paper›PMID 21498513›Full record

ArticleThe Journal of biological chemistry2011

Competing interactions stabilize pro- and anti-aggregant conformations of human Tau.

Susanne Wegmann, Jonas Schöler, Christian A Bippes, Eckhard Mandelkow, Daniel J Muller

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Viscoelastic damage evaluation of the axon.Frontiers in bioengineering and biotechnology · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. The structure and phase of tau: from monomer to amyloid filament.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. NMR Studies of Tau Protein in Tauopathies.Frontiers in molecular biosciences · 2021
    Review
  10. Article
  11. 14-3-3/Tau Interaction and Tau Amyloidogenesis.Journal of molecular neuroscience : MN · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Physical Biology of Axonal Damage.Frontiers in cellular neuroscience · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Susanne WegmannDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.
Jonas Schöler
Christian A Bippes
Eckhard Mandelkow
Daniel J Muller
ETH Zurich · CHFriedrich Miescher Institute · CHGerman Center for Neurodegenerative Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggregation of Tau into amyloid-like fibrils is a key process in neurodegenerative diseases such as Alzheimer. To understand how natively disordered Tau stabilizes conformations that favor pathological aggregation, we applied single-molecule force spectroscopy. Intramolecular interactions that fold polypeptide stretches of ~19 and ~42 amino acids in the functionally important repeat domain of full-length human Tau (hTau40) support aggregation. In contrast, the unstructured N terminus randomly folds long polypeptide stretches >100 amino acids that prevent aggregation. The pro-aggregant mutant hTau40ΔK280 observed in frontotemporal dementia favored the folding of short polypeptide stretches and suppressed the folding of long ones. This trend was reversed in the anti-aggregant mutant hTau40ΔK280/PP. The aggregation inducer heparin introduced strong interactions in hTau40 and hTau40ΔK280 that stabilized aggregation-prone conformations. We show that the conformation and aggregation of Tau are regulated through a complex balance of different intra- and intermolecular interactions.

Indexed as

Protein FoldingAlzheimer DiseaseFrontotemporal DementiaHumansMutationProtein Structure, QuaternaryProtein Structure, Tertiarytau ProteinsMAPT protein, humantau Proteins

Identifiers

PMID21498513
PMCPMC3121454
OpenAlexW1989619965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.